Alimta Approved as First Licensed Treatment for Mesothelioma, a ...

...

Alimta Approved in the European Union for Two Cancer Indications

... Cancer Vaccines 2000, a Report from the World : Onlypunjab.com Team- Entertainment News, Movie News, Music News, Humour News, Outrageous Acts - Onlypunjab.com a:link {color:#000088 ;text-decoration:underline} a:visited {color:#000088; text-decoration:underline} a:hover {color:#B20000; text-decoration : underline} a:active {color:#000088; text-decoration:underline} News Main Cancer Vaccines 2000, a Report from the World Publish Date : 10/16/2004 9:49:00 AM Source : Onlypunjab.com Team Harnessing the exquisite specificity of the immune system to detect and attack cancer cells has long been a dream of cancer immunologists.

Cancer vaccines are getting ever closer to becoming reality as they are shown to consistently and reproducibly stimulate the immune system to attack cancer-specific targets.

Now early-phase clinical trials are beginning to show hints of the promise of immunotherapy.

WHAT: New findings in the development of cancer vaccines from the USA, Australia, Europe and Japan will be presented as part of the International Cancer Immunotherapy Symposia Series.

WHEN: October 4-6, 2004 WHERE: Manhattan Conference Center at the Millenium Broadway Hotel 145 West 45th Street, New York.

WHO: Organized by the Cancer Research Institute, New York.

Speakers are drawn from the international Cancer Vaccine Collaborative, leading US academic groups, and industry efforts.

Over 250 scientists and physicians regi...

Lilly fights stock slump

... IBJ Story If you are an IBJ subscriber, you do not have to purchase this article.

Please log in with your user name and password at the bottom of this page.

VOL.

25 NO.

32, OCT.

18-24, 2004 Lilly fights stock slump The price of Eli Lilly and Co.

shares slid to a 52-week low last week, a day before the company announced the elimination of 575 U.S.

jobs.

Login Full access to the IBJ Web site is an added benefit of having an IBJ subscription.

Subscribers, please use your subscription number, which is located immediately above the name of the addressee on your mailing label, to obtain a user name and password for full access to the site.

NOTE: Subscriber numbers from 4-week trial subscriptions will not grant you access.

If you already have a user name and password, go to the bottom of this page to sign in.

IMPORTANT: Before establishing Web site access to IBJ's articles, please call 317-634-6200 / 1-800-968-1225 M-F and ask for the Web Administrator.

Account maintenance for IBJ's Web site database is necessary, and in most cases will be completed during this phone call.

Thank you.

Subscriber Number: Zip Code: Email Address: Choose Your User Name: Choose Your Password: Remember my login so I do not haveto log in from this computer every timeCheck here If you would like to sign up for an IBJ subscription, please CLICK HERE.

Or call the IBJ at 317-634-6200.

User Name: Password: Remember my login so I do not havet...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news